Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-005025-70Phase 4Completed
Phase 4, randomised trial of hypertonic saline in ocular hypertension, Glaucoma and cataract (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Eyepressure after NaCl bolus or mannitol infusion (primary). Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-005025-70.